生殖道沙眼衣原体分子流行病学研究进展

doi:10.3760/cma.j.issn.0412-4030.2019.08.018

摘要/Abstract

摘要： 【摘要】生殖道沙眼衣原体（Ct）是全球最常见的性病病原体，在很多国家，Ct感染发病率已超过淋球菌感染发病率，位居性病之首。Ct感染可引起男性尿道炎、附睾炎、前列腺炎及不育，女性宫颈炎、子宫内膜炎、盆腔炎、不孕及新生儿结膜炎等多种疾病，并且Ct感染泌尿生殖道后，症状隐匿，易被患者忽视，导致病情迁延、复发或反复感染。此外，Ct感染还可增加人乳头瘤状病毒、艾滋病病毒等性病的感染风险。如何预防控制Ct的传播，已成为全球重要的公共卫生问题。Ct的分子流行病学特征是目前研究的热点，该类研究旨在发现变异菌株、阐明传播动力学、探究菌株型别在不同人群间的分布等，进而为Ct的防控提供分子生物学方面的依据。本文从Ct的流行现状、分子流行病学研究方法及分型在临床的应用等方面进行综述，为Ct的防控及研究提供参考。

关键词: 沙眼衣原体, 衣原体感染, 分子流行病学, 基因分型技术, 多位点测序分型

Abstract: 【Abstract】 Chlamydia trachomatis （Ct） is the causative agent of bacterial sexually transmitted diseases （STDs） worldwide. The incidence of Ct infection has exceeded that of Neisseria gonorrhoeae, and becomes the highest in STDs in many countries. Ct infection can lead to urethritis, epididymitis, prostatitis and infertility in males, and cervicitis, endometritis, pelvic inflammatory disease, infertility in females, and neonatal conjunctivitis. Additionally, urogenital Ct infection is always ignored due to its concealed symptoms, leading to a long clinical course, recurrence or repeated infections. Furthermore, Ct infection can increase the risk of human immunodeficiency virus and human papilloma virus infections. Therefore, how to prevent and control the transmission of Ct has become one of the global public health issues. Currently, a growing body of researches have focused on the molecular epidemiological characteristics of Ct, which are aiming to identify the mutant strains, elaborate transmission dynamics, investigate the distribution of Ct serotypes in different populations, so as to provide molecular epidemiological evidence for the prevention and control of Ct infection. This review summarizes the epidemic status and research methods for molecular epidemiological characteristics of Ct, as well as application of Ct serotyping in clinical practice, providing references for the prevention, control and research of Ct infection.

Key words: Chlamydia trachomatis, Chlamydia infections; , Molecular epidemiology, Genotyping techniques, Multilocus sequence typing

刘兰兰李武孙思张莉张涛吕纯芳陈忠伟罗珍冑陈祥生. 生殖道沙眼衣原体分子流行病学研究进展[J]. 中华皮肤科杂志, 2019, 52(8): 582-585.

Liu Lanlan, Li Wu, Sun Si, Zhang Li, Zhang Tao, Lyu Chunfang, Chen Zhongwei, Luo Zhenzhou, Chen Xiangsheng. Molecular epidemiological characteristics of genital Chlamydia trachomatis[J]. Chinese Journal of Dermatology, 2019, 52(8): 582-585.

参考文献 26

［1］	Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of the prevalence and incidence of four curable sexually trans⁃mitted infections in 2012 based on systematic review and global reporting［J/OL］. PLoS One, 2015,10（12）:e0143304.［2015⁃12⁃08］. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0143304. doi: 10.1371/journal.pone.0143304.
［2］	Adachi K, Xu J, Yeganeh N, et al. Combined evaluation of sexually transmitted infections in HIV⁃infected pregnant women and infant HIV transmission［J/OL］. PLoS One, 2018,13（1）:e0189851.［2018⁃01⁃05］. http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0189851. doi: 10.1371/journal.pone.0189851.
［3］	Qi ML, Guo YL, Wang QQ, et al. Consensus by chinese expert panel on chlamydia trachomatis⁃resistant and chlamydia trachomatis⁃persistent infection［J］. Chin Med J （Engl）, 2017,130（23）:2852⁃2856. doi: 10.4103/0366⁃6999.219159.
［4］	Stefanelli P, Sulis G, Renna G, et al. Chlamydia trachomatis genotypes in school adolescents, Italy［J］. Infection, 2015,43（6）:739⁃741. doi: 10.1007/s15010⁃015⁃0787⁃5.
［5］	Gita S, Suneeta M, Anjana S, et al. C. trachomatis in female reproductive tract infections and RFLP⁃based genotyping: a 16⁃year study from a tertiary care hospital［J］. Infect Dis Obstet Gynecol, 2011,2011:548219. doi: 10.1155/2011/548219.
［6］	Klint M, Fuxelius HH, Goldkuhl RR, et al. High⁃resolution genotyping of Chlamydia trachomatis strains by multilocus sequence analysis［J］. J Clin Microbiol, 2007,45（5）:1410⁃1414. doi: 10.1128/JCM.02301⁃06.
［7］	Zhang JJ, Zhao GL, Wang F, et al. Molecular epidemiology of genital Chlamydia trachomatis infection in Shenzhen, China［J］. Sex Transm Infect, 2012,88（4）:272⁃277. doi: 10.1136/sextrans⁃2011⁃050163.
［8］	Rawre J, Juyal D, Dhawan B. Molecular typing of Chlamydia trachomatis: an overview［J］. Indian J Med Microbiol, 2017,35（1）:17⁃26. doi: 10.4103/ijmm.IJMM_16_341.
［9］	Unemo M, Bradshaw CS, Hocking JS, et al. Sexually transmitted infections: challenges ahead［J］. Lancet Infect Dis, 2017,17（8）:e235⁃e279. doi: 10.1016/S1473⁃3099（17）30310⁃9.
［10］	Rodriguez P, de Barbeyrac B, Persson K, et al. Evaluation of molecular typing for epidemiological study of Chlamydia trachomatis genital infections［J］. J Clin Microbiol, 1993,31（8）:2238⁃2240.
［11］	Hinkan S, Chuerduangphui J, Ekalaksananan T, et al. Anatomical site distribution and genotypes of Chlamydia trachomatis infecting asymptomatic men who have sex with men in northeast Thailand［J］. Int J STD AIDS, 2018,29（9）:842⁃850. doi: 10.1177/ 09564 62418760659.
［12］	Batteiger BE, Wan R, Williams JA, et al. Novel Chlamydia trachomatis strains in heterosexual sex partners, Indianapolis, Indiana, USA［J］. Emerg Infect Dis, 2014,20（11）:1841⁃1847. doi: 10.3201/2011.140604.
［13］	Danby CS, Cosentino LA, Rabe LK, et al. Patterns of extragenital Chlamydia and gonorrhea in women and men who have sex with men reporting a history of receptive anal intercourse［J］. Sex Transm Dis, 2016,43（2）:105⁃109. doi: 10.1097/OLQ.000000000 0000384.
［14］	Piñeiro L, Isaksson J, Zapico M, et al. Chlamydia trachomatis genotypes A and B from urogenital specimens of patients in Spain: molecular characterization［J］. Clin Microbiol Infect, 2018, 24（8）:910.e5⁃910.e8. doi: 10.1016/j.cmi.2018.01.025.
［15］	Andersson P, Harris SR, Seth Smith HM, et al. Chlamydia trachomatis from Australian Aboriginal people with trachoma are polyphyletic composed of multiple distinctive lineages［J］. Nat Commun, 2016,7:10688. doi: 10.1038/ncomms10688.
［16］	Casillas⁃Vega N, Morfín⁃Otero R, García S, et al. Frequency and genotypes of Chlamydia trachomatis in patients attending the obstetrics and gynecology clinics in Jalisco, Mexico and correlation with sociodemographic, behavioral, and biological factors［J］. BMC Womens Health, 2017,17（1）:83. doi: 10.1186/s12905⁃017⁃0428⁃5.
［17］	Gao X, Chen XS, Yin YP, et al. Distribution study of Chlamydia trachomatis serovars among high⁃risk women in China performed using PCR⁃restriction fragment length polymorphism genotyping［J］. J Clin Microbiol, 2007,45（4）:1185⁃1189. doi: 10.1128/JCM. 02076⁃06.
［18］	Taheri Beni B, Motamedi H, Ardakani MR. Genotyping of the prevalent Chlamydia trachomatis strains involved in cervical infections in women in Ahvaz, Iran［J］. J Med Microbiol, 2010,59（Pt 9）:1023⁃1028. doi: 10.1099/jmm.0.016717⁃0.
［19］	Darville T. Chlamydia trachomatis infections in neonates and young children［J］. Semin Pediatr Infect Dis, 2005,16（4）:235⁃244.
［20］	Geisler WM, Uniyal A, Lee JY, et al. Azithromycin versus doxycycline for urogenital Chlamydia trachomatis infection［J］. N Engl J Med, 2015,373（26）:2512⁃2521. doi: 10.1056/NEJMoa 1502599.
［21］	Bhengraj AR, Vardhan H, Srivastava P, et al. Decreased suscepti⁃bility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India［J］. Chemotherapy, 2010,56（5）:371⁃377. doi: 10.1159/000314998.
［22］	de Vrieze NH, van Rooijen M, Speksnijder AG, et al. Urethral lymphogranuloma venereum infections in men with anorectal lymphogranuloma venereum and their partners: the missing link in the current epidemic?［J］. Sex Transm Dis, 2013,40（8）:607⁃608. doi: 10.1097/01.OLQ.0000431359.26583.13.
［23］	Spaargaren J, Fennema HS, Morré SA, et al. New lymphogranuloma venereum Chlamydia trachomatis variant, Amsterdam［J］. Emerg Infect Dis, 2005,11（7）:1090⁃1092. doi: 10.3201/eid1107.040883.
［24］	Stary G, Meyer T, Bangert C, et al. New Chlamydia trachomatis L2 strains identified in a recent outbreak of lymphogranuloma venereum in Vienna, Austria［J］. Sex Transm Dis, 2008,35（4）:377⁃382. doi: 10.1097/OLQ.0b013e31815d6df8.
［25］	Dahlberg J, Hadad R, Elfving K, et al. Ten years transmission of the new variant of Chlamydia trachomatis in Sweden: prevalence of infections and associated complications［J］. Sex Transm Infect, 2018,94（2）:100⁃104. doi: 10.1136/sextrans⁃2016⁃052992.
［26］	Escobedo⁃Guerra MR, Katoku⁃Herrera M, Lopez⁃Hurtado M, et al. Identification of a new variant of Chlamydia trachomatis in Mexico［J/OL］. Enferm Infecc Microbiol Clin, 2018,pii: S0213⁃005X（18）30057⁃0.［2018⁃05⁃28］. https://www.sciencedirect.com/science/article/pii/S0213005X18300570?via3Dihub. doi: 10.1016/j.eimc.2018.02. 008. ［published online ahead of print Apr 7, 2018］.

[1]	邵丽丽马璟玥练婷婷魏世娟任杰刘全忠. 不同途径接种衣原体后小鼠多脏器衣原体检测分析[J]. 中华皮肤科杂志, 2019, 52(8): 554-560.
[2]	雷文波何蓓聂倩文雅婷赵钰琦李忠玉. 沙眼衣原体pORF5质粒蛋白通过HMGB1抑制细胞凋亡机制初步研究[J]. 中华皮肤科杂志, 2019, 52(8): 548-553.
[3]	秦蓓刘全忠. 阿奇霉素与多西环素治疗生殖道沙眼衣原体感染疗效的Meta分析[J]. 中华皮肤科杂志, 2018, 51(9): 691-695.
[4]	陈文韬薛耀华黄进梅杨结仪赵云虎蓝银苑方铭恒郑碧英郑和平. 体外诱导沙眼衣原体持续性感染对宿主细胞凋亡的调控[J]. 中华皮肤科杂志, 2018, 51(5): 347-351.
[5]	练婷婷魏世娟刘原君任杰王生郭媛丽郭睿刘全忠邵丽丽. M13-IN5重组噬菌体的构建与鉴定及其对沙眼衣原体的作用研究[J]. 中华皮肤科杂志, 2018, 51(12): 859-864.
[6]	中国疾病预防控制中心性病控制中心…… 王千秋刘全忠徐金华王宝玺张建中. 梅毒、淋病、生殖器疱疹、生殖道沙眼衣原体感染诊疗指南（2014）[J]. 中华皮肤科杂志, 2014, 47(5): 365-372.
[7]	齐蔓莉王敬刘原君刘全忠陈锦英. 白介素2基因佐剂对沙眼衣原体E型DNA疫苗的免疫增效作用[J]. 中华皮肤科杂志, 2012, 45(5): 322-324.
[8]	李玲杰刘原君姚卫锋侯淑萍田敬群冯斌刘全忠. 临床标本中沙眼衣原体噬菌体Vp1基因及血清Vp1抗体的检测[J]. 中华皮肤科杂志, 2012, 45(5): 315-317.
[9]	李燕刘原君盛彩虹齐蔓莉姚卫峰刘全忠. 沙眼衣原体多形外膜蛋白PmpG的克隆、表达、纯化及鉴定[J]. 中华皮肤科杂志, 2010, 43(8): 568-571.
[10]	李燕刘原君齐蔓莉盛彩虹刘全忠. 沙眼衣原体泌尿生殖道感染患者血清Pmp蛋白抗体的检测[J]. 中华皮肤科杂志, 2010, 43(7): 482-484.
[11]	王梅江勇邵丽丽刘原君侯淑萍刘全忠. 五种常用抗菌药物对泌尿生殖道沙眼衣原体的单独和联合药敏作用[J]. 中华皮肤科杂志, 2010, 43(10): 687-690.
[12]	刘勇刘原君姚卫锋盛彩虹朱辉李燕刘全忠. 低血清铁生殖道沙眼衣原体持续感染动物模型的研究[J]. 中华皮肤科杂志, 2010, 43(10): 702-704.
[13]	杨晓静杨丽娜江勇刘原君刘全忠. 天津地区泌尿生殖道沙眼衣原体临床株药敏分析[J]. 中华皮肤科杂志, 2009, 42(5): 352-354.
[14]	李艳飞刘原君王艳齐蔓莉刘全忠. 沙眼衣原体E型MOMP基因原核表达载体的构建和纯化[J]. 中华皮肤科杂志, 2009, 42(5): 359-360.
[15]	栗玉珍, 尚红, 姚军英, 韩晓旭. 北方汉族衣原体引起盆腔炎患者与HLA-DQ相关性的研究[J]. 中华皮肤科杂志, 2004, 37(5): 278-279.